Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas

 Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas

Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas

Shots:

  • The two partners will jointly enhance the existing platform utilizing One Drop’s know-how and capabilities of the One Drop platform and will co-develop digital health therapies across multiple therapeutic areas               
  • One Drop will receive $98M financing, development fees and commercial milestones while in exchange Bayer will receive royalties on sales. In the future, Bayer may also support the commercialization of the jointly developed digital products
  • The collaboration allows Bayer to accelerate its evolution towards a digital health business with a focus to provide integrated care patient service offerings

Click here ­to­ read full press release/ article | Ref: Bayer | Image: Getty Images

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post